Dronabinol for supportive therapy in patients with malignant melanoma and liver metastases;Dronabinol zur supportiven Therapie metastasierter maligner Melanome mit Lebermetastasen

Hautarzt

Volumn 57, Issue 5, 2006, Pages 423-427

  Zutt, M ^a   Hanssle H ^a   Emmert, S ^a   Neumann, C ^a   Kretschmer, L ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Dronabinol; Loss of appetite; Malignant melanoma; Nausea; Supportive therapy

Indexed keywords

ALPHA INTERFERON; ANTIEMETIC AGENT; DACARBAZINE; DEXAMETHASONE; DIMENHYDRINATE; DRONABINOL; GEMCITABINE; METENOLONE ACETATE; METOCLOPRAMIDE; ONDANSETRON; TEMOZOLOMIDE; TREOSULFAN; TROFOSFAMIDE; TROPISETRON; VINDESINE;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIZZINESS; DRUG CONTRAINDICATION; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MELANOMA; NAUSEA; QUALITY OF LIFE;

ADULT; AGED; ANALGESICS, NON-NARCOTIC; CHEMOTHERAPY, ADJUVANT; EATING DISORDERS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NAUSEA; PALLIATIVE CARE; QUALITY OF LIFE; SKIN NEOPLASMS; TETRAHYDROCANNABINOL; TREATMENT OUTCOME;

EID: 33646589959     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-005-1063-x     Document Type: Article

References (12)

1. Beal JE, Olson R, Laubenstein L et al. (1995) Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage 10(2):89-97
2. Bifulco M, Di Marzo V (2003) The endocannabinoid system as a target for the development of new drugs for cancer therapy. Recenti Prog Med 94(5):194-198
3. Forth W, Henschler D, Rummel W, Starke K (1992) Allgemeine und spezielle Pharmakologie und Toxikologie. BI Wissenschaftverlag, Mannheim Leipzig Wien Zürich, S 298-299
4. Gonzales-Rosales F, Walsh D (1997) Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (dronabinol). J Pain Symptom Manage 14(5):311-314
5. Grotenhermen F (2003) Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 42(4):327-360
6. Iversen L (2003) Cannabis and the brain. Brain 126:1252-1270
7. Jatoi A, Windschitl HE, Loprinzi CL et al. (2002) Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol 20(12):2912-2913
8. Kraft B, Kress HG (2004) Cannabinoide und Immunsystem. Schmerz 18:203-210
9. Pertwee RG (1999) Cannabis and cannabinoids: pharmacology and rationale for clinical use. Forsch Komplementärmed 6 [Suppl3]:12-15
10. Rommelspacher H (2000) Cannabis - Als Arzneimittel nur von geringem therapeutischen Nutzen. Dtsch Ärztebl 51/52:2918-2919
11. Wadleigh R, Spaulding GM, Lumbersky B (1990) Dronabinol enhancement of appetite in cancer patients. Proc Am Soc Oncology 9:331
12. Walsh D, Nelson KA, Mahmoud FA (2003) Established and potential therapeutic applications of cannabinoids in oncology. Support Car Cancer 11:137-143